Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.209
-0.036 (-14.82%)
At close: Apr 28, 2026, 4:00 PM EDT
0.204
-0.005 (-2.37%)
After-hours: Apr 28, 2026, 4:28 PM EDT
Aspire Biopharma Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 0.01 | - | - | - |
| Cost of Revenue | 0.01 | - | - | - |
| Gross Profit | -0 | - | - | - |
| Selling, General & Admin | 4.3 | 1.07 | 0.29 | 0.42 |
| Research & Development | 0.92 | 0.14 | 0.07 | 0.18 |
| Operating Expenses | 5.22 | 1.21 | 0.36 | 0.6 |
| Operating Income | -5.22 | -1.21 | -0.36 | -0.6 |
| Interest Expense | -8.53 | -0.1 | - | - |
| Other Non Operating Income (Expenses) | 3.77 | - | - | - |
| EBT Excluding Unusual Items | -9.99 | -1.31 | -0.36 | -0.6 |
| Merger & Restructuring Charges | -14.13 | - | - | - |
| Other Unusual Items | -0.36 | - | - | - |
| Pretax Income | -24.48 | -1.31 | -0.36 | -0.6 |
| Income Tax Expense | - | 0 | 0 | 0 |
| Net Income | -24.48 | -1.31 | -0.36 | -0.6 |
| Net Income to Common | -24.48 | -1.31 | -0.36 | -0.6 |
| Shares Outstanding (Basic) | 1 | 1 | 443 | - |
| Shares Outstanding (Diluted) | 1 | 1 | 443 | - |
| Shares Change (YoY) | 116.69% | -99.84% | - | - |
| EPS (Basic) | -16.38 | -1.90 | -0.00 | - |
| EPS (Diluted) | -16.38 | -1.90 | -0.00 | - |
| Gross Margin | -1.87% | - | - | - |
| Operating Margin | -84167.06% | - | - | - |
| Profit Margin | -394725.06% | - | - | - |
| EBIT | -5.22 | -1.21 | -0.36 | -0.6 |
Source: S&P Capital IQ. Standard template.
Financial Sources.